Antidepressant-selective gynecomastia.
CONCLUSIONS: Gynecomastia is associated with antidepressants and other medications but is rarely addressed. Gynecomastia may be antidepressant selective or may be the result of additive adverse effects. Clinicians are advised to question patients regarding this potential adverse effect. Further education of clinicians is indicated.
PMID: 23324513 [PubMed - in process]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Kaufman KR, Podolsky D, Greenman D, Madraswala R Tags: Ann Pharmacother Source Type: research
More News: Alprazolam | Anxiety | Crestor | Cymbalta | Depression | Diabetes | Drugs & Pharmacology | Education | Endocrinology | Fortamet | Gynecomastia | Hormones | Hydrochlorothiazide | Hypertension | Janumet | Januvia | Mammography | Metformin | Neurology | Norvasc | Obsessive Compulsive Disorder | Rosuvastatin | Sertraline | Social Anxiety Disorder | Toprol | Universities & Medical Training | Xanax | Zoloft